BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/5/2023 3:12:10 AM | Browse: 379 | Download: 1277
 |
Received |
|
2022-10-16 08:40 |
|
Peer-Review Started |
|
2022-10-16 08:42 |
|
First Decision by Editorial Office Director |
|
2022-11-04 08:27 |
|
Return for Revision |
|
2022-11-04 08:27 |
|
Revised |
|
2022-11-10 12:17 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-12-16 03:35 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-12-16 10:00 |
|
Articles in Press |
|
2022-12-16 10:00 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-12-26 05:48 |
|
Publish the Manuscript Online |
|
2023-01-05 03:12 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sehan Kim, Jong Hee Sun, Hongsik Kim, Hee Kyung Kim, Yaewon Yang, Jun Su Lee, In Ah Choi and Hye Sook Han |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hye Sook Han, MD, Professor, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, 1 Chungdae-ro, Seowon-gu, Cheongju 28644, South Korea. hyesukhan@chungbuk.ac.kr |
| Key Words |
Pembrolizumab; Psoriatic arthritis; Disease-modifying anti-rheumatic drugs; Gastric cancer; Case report |
| Core Tip |
Although immune checkpoint inhibitors are being used increasingly and widely, a fair percentage of patients treated with these drugs experience immune-related adverse events (irAEs). Arthralgia and skin lesions are among the most frequent irAEs. However, rheumatic irAEs are underreported and/or misclassified and have been poorly characterized. These rheumatic irAEs are different in simple arthralgia or cutaneous irAEs that they may be requiring long-term management and disease-modifying anti-rheumatic drugs in severe or refractory case. We report a first case of pembrolizumab-induced psoriatic arthritis that was treated with tumor necrosis factor-α inhibitors in a patient with gastric cancer and discuss the treatment course. |
| Publish Date |
2023-01-05 03:12 |
| Citation |
Kim S, Sun JH, Kim H, Kim HK, Yang Y, Lee JS, Choi IA, Han HS. Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report. World J Clin Cases 2023; 11(1): 218-224 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i1/218.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i1.218 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
